| Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results - CNNMoney.com (press release) |
|
|
CNNMoney.com (press release)Zerenex has recently completed a Phase 2 clinical program as a treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal ... read more |